ASCENTAGE PHARMA
Live / Registered — Registered — Section 71 accepted (as of 12 Sept 2026)
What this means for you
Registered since 08 Oct 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Oct 2029: the §71 ten-year affidavit of use).
Record
- Serial number
- 79246610
- Registration number
- 5876589
- Mark type
- Word mark
- Filed
- 10 Aug 2018
- Published for opposition
- 23 Jul 2019
- Registered
- 08 Oct 2019
- Next maintenance filing
- §71 ten-year affidavit of use, due by 08 Oct 2029 (grace period to 08 Apr 2030)
- Attorney of record
- Kathryn E. Smith
Goods and services
- Class 005 — Pharmaceuticals: Medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; [ bacterial poisons; ] pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; [ chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; ] drugs for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease [ ; medicines for dental purposes; antibiotics; pharmaceutical preparations in the form of injection for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of tablet for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; active pharmaceutical ingredients in the nature of drug delivery agents in the form of powders, liquids, and capsules that provide controlled release of active ingredients for a wide variety of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; active pharmaceutical ingredients for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; suppositories; medicinal oils; transdermal patches for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; candy, medicated; candy for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic substances adapted for medical use; mineral food supplements; nutritional supplements ]
Owner
Prosecution history
- 12 Sept 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 12 Sept 2026 — REGISTERED-SEC.71 ACCEPTED
- 27 Jul 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Apr 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 Apr 2026 — TEAS SECTION 71 RECEIVED
- 07 Nov 2025 — CHANGE OF OWNER RECEIVED FROM IB
- 21 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Aug 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 21 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Oct 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 01 Apr 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 01 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED